In vivo anticancer activity of rhomboidal Pt(II) metallacycles

98Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

The development of novel antitumor agents that have high efficacy in suppressing tumor growth, have low toxicity to nontumor tissues, and exhibit rapid localization in the targeted tumor sites is an ongoing avenue of research at the interface of chemistry, cancer biology, and pharmacology. Supramolecular metal-based coordination complexes (SCCs) have well-defined shapes and geometries, and upon their internalization, SCCs could affect multiple oncogenic signaling pathways in cells and tissues. We investigated the uptake, intracellular localization, and antitumor activity of two rhomboidal Pt(II)-based SCCs. Laser-scanning confocal microscopy in A549 and HeLa cells was used to determine the uptake and localization of the assemblies within cells and their effect on tumor growth was investigated in mouse s.c. tumor xenograft models. The SCCs are soluble in cell culture media within the entire range of studied concentrations (1 nM-5 μM), are nontoxic, and showed efficacy in reducing the rate of tumor growth in s.c. mouse tumor xenografts. These properties reveal the potential of Pt(II)-based SCCs for future biomedical applications as therapeutic agents.

Cite

CITATION STYLE

APA

Grishagin, I. V., Pollock, J. B., Kushal, S., Cook, T. R., Stang, P. J., & Olenyuk, B. Z. (2014). In vivo anticancer activity of rhomboidal Pt(II) metallacycles. Proceedings of the National Academy of Sciences of the United States of America, 111(52), 18448–18453. https://doi.org/10.1073/pnas.1418712111

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free